
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
The author describes the efforts of the standards committees to establish guidelines for PAT implementation and the impact of the guidelines on the industry.






